In an intriguing development in the field of healthcare and antitrust law, hospital acquisitions in Louisiana may elude Federal Trade Commission (FTC) review under the Hart-Scott-Rodino Antitrust Improvements Act (HSR Act). This conclusion arises from a recent federal district court decision that may soon become settled law. If this happens, more hospital acquisitions may attempt to circumvent premerger assessment from the FTC and, in fact, any antitrust inquiry as such.
Insight into this ongoing matter can be found through an article provided by law firm Manatt, Phelps & Phillips, LLP. According to their discussion, the legal precedent being formed has the potential to produce a significant shift in the practices surrounding hospital acquisitions, barring them from being subject to FTC and other antitrust examinations.Full text of the article…
As we track the progress of this situation, law practitioners and corporations need to stay well-informed regarding the evolving legal landscape surrounding healthcare mergers and acquisitions. As this development potentially augurs a shift in FTC prerogatives and legislative oversight, this case represents a critical watch point for legal professionals and healthcare organizations.